P
Patricia Campbell
Publications - 4
Citations - 656
Patricia Campbell is an academic researcher. The author has contributed to research in topics: End stage renal disease & Hemodialysis. The author has an hindex of 4, co-authored 4 publications receiving 641 citations.
Papers
More filters
Journal ArticleDOI
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Robert N. Foley,Patrick S. Parfrey,Janet Morgan,Paul E. Barre,Patricia Campbell,Pierre Cartier,Douglas Coyle,Adrian Fine,Paul Handa,Iris Kingma,Cathy Y. Lau,Adeera Levin,David C. Mendelssohn,Norman Muirhead,T. Brendan Murphy,Richard K. Plante,Gerald A. Posen,George A. Wells +17 more
TL;DR: Normalization of hemoglobin does not lead to regression of established concentric LV hypertrophy or LV dilation, and it may, however, prevent the development of LV dilated and it leads to improved quality of life.
Journal ArticleDOI
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
Sean Murphy,Robert N. Foley,Brendan J. Barrett,Gloria M. Kent,Janet Morgan,Paul E. Barre,Patricia Campbell,Adrian Fine,Marc Goldstein,S. Paul Handa,Kailash Jindal,Adeera Levin,Henry Mandin,Norman Muirhead,Robert M. Richardson,Patrick S. Parfrey +15 more
TL;DR: The apparent survival advantage of peritoneal dialysis in Canada is due to lower comorbidity and a lower burden of acute onset end-stage renal disease at the inception of dialysis therapy.
Journal ArticleDOI
Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada
Sean Murphy,Robert N. Foley,Brendan J. Barrett,Gloria M. Kent,Janet Morgan,Paul E. Barre,Patricia Campbell,Adrian Fine,Marc Goldstein,S. Paul Handa,Kailash Jindal,Adeera Levin,Henry Mandin,Norman Muirhead,Robert M. Richardson,Patrick S. Parfrey +15 more
TL;DR: Comparisons of hemodialysis and peritoneal dialysis rates are heavily dependent on the analytic starting point and on whether intention-to-treat or treatment-received analyses are used, and early treatment switches are accounted for.
Journal ArticleDOI
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl.
Kevin J. Martin,Harald Jüppner,Donald J. Sherrard,William G. Goodman,Mark R. Kaplan,George N. Nassar,Patricia Campbell,Mario Curzi,Chaim C. Harytan,Laura C. McCary,Matthew Guo,Stewart A. Turner,David A. Bushinsky +12 more
TL;DR: The data show that PTH can be monitored with either iPTH or biPTH assays during therapy with cinacalcet, and that cinacancet therapy does not exert a major influence on the ratio between PTH(1-84) and large, N-terminally truncated PTH fragments.